Lone
Lone Andersen, Middlefart DK
Patent application number | Description | Published |
---|---|---|
20090130250 | Biodegradable Chewing Gum and Method of Manufacturing Such Chewing Gum - The invention relates to a chewing gum including gum base, sweetener, and flavor, wherein at least part of the gum base comprises includes at least one biodegradable polymer, where the tan(delta) is at least 0.6 within the linear viscoelastic region of the chewing gum. | 05-21-2009 |
Lone Andersen, Middelfart DK
Patent application number | Description | Published |
---|---|---|
20110256262 | Low Moisture Chewing Gum - A chewing gum includes at least one biodegradable polymer and chewing gum ingredients, the chewing gum containing less than about 2.0 weight percent water of the chewing gum. A biodegradable chewing gum having low moisture has been provided in combination with an initial acceptable texture. | 10-20-2011 |
20130045298 | Low Moisture Chewing Gum - A chewing gum includes at least one biodegradable polymer and chewing gum ingredients, the chewing gum containing less than about 2.0 weight percent water of the chewing gum. A biodegradable chewing gum having low moisture has been provided in combination with an initial acceptable texture. | 02-21-2013 |
20140065242 | Biodegradable Chewing Gum Comprising At Least One High Molecular Weight Biodegradable Polymer - A chewing gum including at least one biodegradable polymer, wherein the molecular weight of the polymer is at least 105,000 g/mol (Mn). According to the invention, it has moreover been realized that various problems associated with the prior art may be effectively dealt with by increasing the molecular weight of at least one of the biodegradable polymers in the chewing gum when compared to conventional chewing gum polymers and thereby increasing the robustness of the chewing gum with respect to softeners, emulsifiers and e.g. flavor. | 03-06-2014 |
Lone Baekgaard, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20130280375 | BREWING METHOD - A method of improving colloidal stability in beer comprising contacting a mash and/or a wort with a snapalysin during the production of beer. In this process, the foam stability is not affected. | 10-24-2013 |
20150118355 | Brewing Method - This invention relates to wort making for brewing and non alcoholic beverages. More particularly it relates to methods for preparing a wort comprising a high level of free amino acids employing use of various enzymes including different exogenous proteases, for example an endoprotease and an exopeptidase. | 04-30-2015 |
20160053211 | Polypeptides Having Protease Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having protease activity, and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of using the polypeptides in beer production. | 02-25-2016 |
Lone Baekgaard, Fredericksberg DK
Patent application number | Description | Published |
---|---|---|
20120058219 | BREWING METHOD - A method of brewing a beer comprising contacting a mash during lautering, and/or a wort after lautering but before wort boiling, with a thermostable protease. | 03-08-2012 |
Lone Baunsgaard, Helsingoer DK
Patent application number | Description | Published |
---|---|---|
20150132831 | Compositions Comprising Lipase and Methods of Use Thereof - The invention relates to a cleaning composition comprising a lipase with at least 75% identity to SEQ ID NO: 2, and a surfactant, wherein said composition is more effective in removing lipid stains present at a surface in comparison with an equivalent composition lacking the lipase. | 05-14-2015 |
20160053240 | Polypeptides Having Lipase Activity and Polynucleotides Encoding Same - The present invention relates to isolated polypeptides having lipase activity and polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. | 02-25-2016 |
Lone Fjord-Larsen, Rødovre DK
Patent application number | Description | Published |
---|---|---|
20160045564 | THERAPEUTIC USE OF A GROWTH FACTOR, METRNL - The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects. | 02-18-2016 |
Lone Fjord-Larsen, Rodovre DK
Patent application number | Description | Published |
---|---|---|
20110112035 | THERAPEUTIC USE OF A GROWTH FACTOR, METRNL - The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects. | 05-12-2011 |
20130267464 | THERAPEUTIC USE OF A GROWTH FACTOR, METRNL - The present invention relates to the field of therapeutic use of proteins, genes and cells, in particular to the therapy based on the biological function of a secreted therapeutic protein, METRNL, in particular for the treatment of disorders of the nervous system. METRNL is a Nerve Survival and Growth factor with neuroprotective and/or neurogenesis effects. | 10-10-2013 |
Lone Helboe, Frederiksberg DK
Patent application number | Description | Published |
---|---|---|
20140371430 | Antibodies Specific to Pyroglutamated Abeta - The present disclosure relates to antibodies specific for pyroglutamated Aβ, as well as their use in the treatment of Alzheimer's disease and as use in diagnostic methods or as diagnostic imaging ligands Further, is provided pyroglutamated N-terminal fragments of murine or human Aβ to generate antibodies and for use m therapeutic purposes | 12-18-2014 |
Lone Munch Ringgard, Roskilde DK
Patent application number | Description | Published |
---|---|---|
20110053957 | MALONATE SALT OF 4-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE AND USES OF SAME - 4-((1R,35)-6-Chloro-3 -phenylindan-1-yl)-1,2,2-trimethylpiperazine hydrogen malonate salt and pharmaceutical comprising and uses of the same, including for the treatment of schizophrenia and other psychotic disorders are described. | 03-03-2011 |
Lone Munch Ringgard, Copenhagen Nv DK
Patent application number | Description | Published |
---|---|---|
20100324291 | PROCESSES FOR 4-((1R,3S)-6-CHLORO-3-PHENYLINDAN-1-YL)-1,2,2-TRIMETHYLPIPERAZINE OR A SALT THEREOF - Methods for the preparation of 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and salts thereof are described. | 12-23-2010 |
Lone Pridal, Greve DK
Patent application number | Description | Published |
---|---|---|
20150111820 | NOVEL USE OF INSULIN DERIVATIVES - This invention relates to insulin derivatives having long duration of action. The insulin derivatives have been found to be useful for the treatment of diabetes, and in particular for less frequent administration to the diabetic patients, in particular as seldom as about once weekly. | 04-23-2015 |
Lone Risegaard, Brondby Strand DK
Patent application number | Description | Published |
---|---|---|
20100022456 | Dimeric Prolactin Receptor Ligands - The patent application relates to antagonistic dimers of prolactin molecules and their use in treating cancer. | 01-28-2010 |
Lone Tang, Hoejbjerg DK
Patent application number | Description | Published |
---|---|---|
20150291992 | METHOD AND APPARATUS FOR DETERMINING MICROORGANISMS IN A WATER SAMPLE - The invention relates to an apparatus and method for determining presence of microorganisms in, e.g., sea water or other water samples. Means are provided for taking a sample of the water to be tested, moving it through a series of reservoirs, and combining it with an indicator, such as a dye, which binds to DNA of any microorganisms in the sample. Any binding of indicator is measured by, e.g., a spectrofluorometer, or other device suitable for measuring the indicator. | 10-15-2015 |
Lone Wolinsky, Ramat Gan IL
Patent application number | Description | Published |
---|---|---|
20090270742 | DEVICES FOR FIXING A SENSOR IN A LUMEN - Apparatus for positioning at least one sensor in a body lumen, the apparatus including a fixation element, a sensor, and a connecting element that connects the sensor to the fixation element, the connecting element extending at least partially into the lumen so that the sensor is located radially inward from a wall of the lumen. | 10-29-2009 |
20100152748 | Devices, Systems, and Methods Providing Body Lumen Access - Devices and methods are provided which include access port devices for implantation through a tissue wall of a lumen of patient's body and for containing electrical leads therein. An implantable port device includes a body with a first end having a first opening and an opposed second end having a second opening, and a channel extending from between and operably connecting the first opening and the second opening; a first retaining member extending radially from the first end of the body; and a second retaining member spaced apart from the first retaining member, the second retaining member being closer than the first retaining member to the second end of the body, and extending radially from the second end of the body. The first retaining member and the second retaining member are configured to cooperatively engage opposing sides of the tissue wall about edges of an aperture through the tissue wall to secure the body within the aperture. | 06-17-2010 |
20110087270 | Vasculature Closure Devices and Methods - Vasculature closure devices, and systems and methods for their use, are provided. In one embodiment, the vasculature closure device includes an expandable support frame deployable within a vessel and a sealing membrane at least partially supported by the expandable support frame. Upon expanding the support frame, the vasculature closure device is configured to intraluminally position the sealing membrane against a puncture site existing in a vessel wall. | 04-14-2011 |
20150094759 | VASCULATURE CLOSURE DEVICES AND METHODS - Vasculature closure devices, and systems and methods for their use, are provided. In one embodiment, the vasculature closure device includes an expandable support frame deployable within a vessel, a sealing membrane at least partially supported by the support frame, and a cross-member support extending across at least a portion of the sealing membrane. Upon expanding the support frame, the device is configured to intraluminally position the sealing membrane against a puncture site existing in a wall of the vessel. The cross-member support includes a flexible wire coupled to the sealing membrane at an intermediate portion of the flexible wire and configured to maintain the sealing membrane against the puncture site. | 04-02-2015 |
20150119928 | VASCULATURE CLOSURE DEVICES - Vasculature closure devices, and systems and methods for their use, are provided. In one embodiment, the vasculature closure device includes an expandable support frame deployable into a vessel through a puncture site and a sealing membrane at least partially supported by the expandable support frame. The support frame is positioned along a periphery of the sealing membrane. Upon expanding the support frame within the vessel, the support frame is configured to intraluminally push the sealing membrane against the puncture site. | 04-30-2015 |
20150119929 | VASCULATURE CLOSURE METHODS - Vasculature closure devices, and systems and methods for their use, are provided. In one embodiment, the method includes deploying a vasculature closure device including a support frame and a sealing membrane into a vessel through a puncture site, wherein the support frame is in a collapsed configuration during deployment, and expanding the support frame into an expanded configuration within the vessel such that the sealing membrane is pushed against the puncture site. | 04-30-2015 |